Jim Olson discusses Tumor Paint 
and Project Violet at TEDx

Press Releases

Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma ​
May 9, 2019

Blaze Bioscience Announces the Initiation of Pivotal Clinical Trial for Tumor Paint: BLZ-100 (tozuleristide) and the Canvas Imaging System​
November 28, 2018

Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at Pediatric Neuro-Oncology Basic and Translational Research Conference
June 15, 2017

Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at the American Society of Breast Surgeons (ASBrS) Annual Meeting
April 27, 2017

Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology
March 28, 2017

Blaze Bioscience Announces Trial in Progress Presentation at ASCO 2016 Annual Meeting
May 31, 2016

Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in JAMA Otolaryngology Head & Neck Surgery 
February 25, 2016

Blaze Bioscience to Present Tumor Paint BLZ-100 at SPIE Photonics West Conference
February 11, 2016

Blaze Bioscience to Present Tumor Paint Clinical Data at 20th Annual Society for Neuro-Oncology (SNO) Meeting
November 9, 2015

Blaze Bioscience Announces Presentation at GAC-SC 2015 Conference
October 27, 2015

Blaze Bioscience Announces Publication of Tumor Paint BLZ-100 Data in Cancer Research
October 15, 2015

Blaze Bioscience Commences Clinical Trial of BLZ-100 in Patients with Sarcoma Undergoing Surgery
September 22, 2015
​
Blaze Bioscience Announces Open Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Patients with Solid Tumor Cancers
July 14, 2015

Blaze Bioscience's BLZ-100 Receives Orphan Drug Designation from FDA for Brain Cancer
July 7, 2015

Blaze Bioscience Announces Open Enrollment for Phase 1 Clinical Trial of Tumor Paint BLZ-100 in Children with Brain Cancer
June 4, 2015

Blaze Bioscience Announces Poster Presentation at ASCO 2015 Annual Meeting
May 27, 2015

Blaze Bioscience Appoints Jan Öhrström, M.D., to Its Board of Directors
April 1, 2015

Blaze Bioscience Announces Poster Presentation at the American Academy of Dermatology 73rd Annual Meeting
March 18, 2015

Blaze Bioscience Announces NCI SBIR Phase II Funding for Clinical Trial of Tumor PaintTM BLZ-100 in Sarcoma
October 8, 2014

Blaze Bioscience Announces Initiation of Phase 1b Brain Cancer Program for Tumor PaintTM BLZ-100
September 25, 2014

Blaze Bioscience Announces Presentation at the 2014 Wedbush PacGrow Life Sciences Management Access Conference
August 13, 2014

Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100
December 19, 2013

Blaze Bioscience Raises $9 million in Series B Financing
December 3, 2013
​​
Blaze Bioscience and Fred Hutchinson Cancer Research Center Enter into Collaboration and Option Agreement in Support of Optides Discovery Program
July 3, 2013

Blaze Bioscience Announces Two Poster Presentations at AACR-SNMMI Conference and Award of NCI SBIR Contract Advancing Tumor Paint™ Technology
February 27, 2013

Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million
February 22, 2013
​
Blaze Bioscience Raises $5.0 Million in Series A Financing
June 8, 2012 

Blaze Bioscience Licenses Tumor Paint Technology from Fred Hutchinson Cancer Research Center
October 18, 2011
​

Media

Scorpion Venom Could Help to Detect Brain Tumors: Study
May 10, 2019
Newsweek

Novel imaging agent utilizes protein found in scorpion venom
May 10, 2019
Health Imaging

Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas
May 9, 2019
Neurosurgery Now!

Blaze Bio posts phase 1 data for cancer-illuminating 'tumor paint'
May 9, 2019
Fierce Biotech

Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial
May 9, 2019
GeekWire

How scorpion venom helps improve brain cancer surgery in children by making tumors glow
February 26, 2019
GeekWire

Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue
February 20, 2019
Xconomy

Lighting the Way for Children With Brain Tumors
February 20, 2019
Seattle Children's Hospital

Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors
October 5, 2017
Puget Sound Business Journal

What 'Sunday Morning' Didn't Say About How Animals Aid Cancer Research​
March 12, 2017
Forbes

On The Horizon: Scorpion venom as cancer treatment
March 12, 2017
CBS Sunday Morning

How Scorpion Venom Is Helping Doctors Treat Cancer
October 19, 2016
Smithsonian.com

Tumor Paint Brings Light to Toddler's Brain Tumor
September 22, 2016
Seattle Children's Hospital

Light at the End of the Scalpel
September 1, 2015
Mosaic Science

Doctors Test Tumor Paint In People
April 8, 2015
NPR Morning Edition

Armed with a poisonous scorpion and glowing Tumor Paint, Blaze Bioscience takes on cancer
July 9, 2014
Puget Sound Business Journal

One Doctor's Quest to Save People by Injecting Them With Scorpion Venom
June 24, 2014
WIRED Magazine

Blaze CEO, Heather Franklin, recognized as EY Pacific Region Entrepreneur of the Year Finalist
May 2, 2014
Ernst & Young

26 Amazing Startups You Need to Watch in 2014
December 31, 2013
Venture Beat Top Startup List

Treating Kids' Cancer With Science and A Pocket Full of Hope
September 13, 2013
Blaze Co-Founder Dr. Jim Olson Featured on NPR Morning Edition

Why Painting Tumors Could Make Brain Surgeons Better
September 12, 2013
NPR

Blaze Bioscience's brilliant concept in the fight against cancer 
September 2012
Seattle Business Magazine​

Blaze Co-Founder Dr. Jim Olson Featured in Promotional Video
May 14, 2012 

Blaze Bioscience President and CEO Heather Franklin will speak at Xconomy Forum: Reinventing Biotech’s Business Model
April 3, 2012
Xconomy

Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors
October 18, 2011
Xconomy